LABA/LAMA versus LABA/ICS fixed-dose combinations in the prevention of COPD exacerbations: a modeling analysis of literature aggregate data

被引：0
|
作者：
Yiwen Gong
Zichao Sui
Yinghua Lv
Qingshan Zheng
Lujin Li
机构：
[1] University of Traditional Chinese Medicine,Center for Drug Clinical Evaluation Shanghai
来源：
European Journal of Clinical Pharmacology | 2023年 / 79卷
关键词：
Chronic obstructive pulmonary disease; LABA/LAMA fixed-dose combinations; LABA/ICS fixed-dose combinations; COPD exacerbations; Model-based meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1321 / 1332
页数：11
相关论文
共 50 条
  • [31] Fixed-dose combination of three drugs, i.e. LABA/LAMA/ICS for COPD: Results of a real-world study from India
    Salvi, Sundeep
    Deb, Ashish Kumar
    Agarwal, Mayank
    Tummuru, Venkateswara Reddy
    Kodgule, Rahul
    Hemalatha, V. S.
    Awasthi, Anil Kumar
    Suraj, K. P.
    Pavitran, Vinod Kumar
    Mourya, Shashi Prakash
    Thomas, Paul
    Vaidya, Abhijit
    Chhowala, Sushmeeta
    Gogtay, Jaideep
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2020, 63
  • [32] Effectiveness of fixed ICS/LABA combinations in COPD - A population based register linkage study
    Stallberg, Bjorn
    Janson, Christer
    Lisspers, Karin
    Johansson, Gunnar
    Jorgensen, Leif
    Stratelis, Georgios
    Telg, Gunilla
    Larsson, Kjell
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [33] Efficacy and safety of ICS/LABA/LAMA FDCs in COPD: a network meta-analysis
    Rogliani, P.
    Cazzola, M.
    Verri, S.
    Camardelli, F.
    Calzetta, L.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [34] Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
    Rogliani, Paola
    Cavalli, Francesco
    Chetta, Alfredo
    Cazzola, Mario
    Calzetta, Luigino
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 565 - 577
  • [35] DEMOGRAPHICS AND CLINICAL CHARACTERISTICS OF PATIENTS WITH COPD UTILIZING LAMA/LABA FIXED-DOSE COMBINATION THERAPY: A US DATABASE STUDY
    Ding, B.
    Kallenbach, L.
    Slipski, L.
    Wilk, A.
    O'Brien, D.
    Guranlioglu, D.
    THORAX, 2018, 73 : A233 - A233
  • [36] COST-EFECTIVENESS ANALYSIS OF AN INTERVENTION TO REDUCE THE CRITICAL HANDLING ERRORS OF FIXED-DOSE ICS/LABA COMBINATIONS IN ASTHMA PATIENTS IN SPAIN
    Collar Martinez, J. M.
    Roman, M.
    Dominguez, J.
    Perez del Llano, L.
    Crespo, C.
    VALUE IN HEALTH, 2019, 22 : S875 - S875
  • [37] Late Breaking Abstract - Impact of ICS/LABA and LABA/LAMA FDCs on lung function and exacerbation of COPD: a network meta-analysis
    Di Marco, Fabiano
    Calzetta, Luigino
    Rogliani, Paola
    Blasi, Francesco
    Centanni, Stefano
    Micheletto, Claudio
    Rossi, Andrea
    Cazzola, Mario
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [38] Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma
    Su, Vincent Yi-Fong
    Yang, Kuang-Yao
    Yang, Yao-Hsu
    Tsai, Ying-Huang
    Perng, Diahn-Warng
    Su, Wei-Juin
    Chou, Kun-Ta
    Su, Kang-Cheng
    Yen, Yung-Feng
    Chen, Pau-Chung
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (06): : 1927 - +
  • [39] Comparison of COPD health care utilization and associated costs across patients treated with LAMA plus LABA fixed-dose therapies
    Palli, Swetha R.
    Xie, Bin
    Chastek, Benjamin
    Elliott, Caitlin A.
    Bengtson, Lindsay G. S.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (07): : 810 - 824
  • [40] RELATIVE EFFICACY AND SAFETY OF INHALED GLYCOPYRRONIUM plus FORMOTEROL FUMARATE DIHYDRATE VERSUS OTHER LAMA plus LABA FIXED-DOSE COMBINATIONS IN COPD: A SYSTEMATIC REVIEW AND BAYESIAN NETWORK META-ANALYSIS
    Siddiqui, M. K.
    Singh, I.
    Jenkins, M.
    Darken, P.
    Guranlioglu, D.
    THORAX, 2018, 73 : A233 - A234
12345